Gilead’s Kite to Collaborate with Shoreline for CAR NK Therapies
By Shikha Kashyap
Pharma Deals Review: Vol 2021 Issue 7 (Table of Contents)
Published: 27 Jul-2021
DOI: 10.3833/pdr.v2021.i7.2628 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
In a move to bolster its cell therapies offering, Kite Pharma, a Gilead company agreed to collaborate with Shoreline Biosciences to develop novel cell therapies across a variety of cancer targets...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS